InvestorsHub Logo
Followers 13
Posts 349
Boards Moderated 0
Alias Born 02/03/2011

Re: None

Wednesday, 02/05/2020 12:18:36 PM

Wednesday, February 05, 2020 12:18:36 PM

Post# of 9850
Why Q4 Should Impress:

The shorts have unfortunately taken hold of the stock - I don't see too much more downside to it... and if I was a betting man I think Q4 will be impressive and that momentum will carry through to 2020.

Some things to note from the Q3-2019 conference call:

- They brought on 32 new plasma centers on September 30th - meaning this extra revenue will count for the entire Q4.
- They also signed up four new programs on the pharma side in Q3
- They also launched a pilot of the premier card.
- Q4 is seasonally their strongest Quarter


Time to take advantage of this gift of a share price...

E.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAYS News